Grabar Law Office Investigates Claims for Long-Term Shareholders of Badger Meter, GeneDx, GRAIL, and Verra Mobility

GlobeNewswire··Read original
2▲0 ▼4Impact / 5
Summary · why it matters

Grabar Law Office is investigating claims on behalf of long-term shareholders of Badger Meter, GeneDx Holdings, GRAIL, and Verra Mobility, concerning whether certain officers and directors breached their fiduciary duties. For Badger Meter, a recently filed federal securities class action alleges that the company attributed strong financial performance to sustainable demand-driven growth while results were materially impacted by pull-forward of customer orders, masking weakening demand trends, and the truth emerged through disappointing quarterly announcements in 2025 and 2026 that caused significant stock declines. For GeneDx, a securities fraud class action alleges that executives made false statements about the Fabric acquisition improving financials and creating efficiencies, when they knew of significant problems in Fabric's viability that would negatively impact the business. For GRAIL, a complaint alleges that officers misled investors about the likelihood that the NHS-Galleri cancer screening trial would meet its primary endpoint, and the stock fell more than 50% in a single day after the company announced on February 19, 2026 that the trial failed to achieve a statistically significant reduction in late-stage cancers. For Verra Mobility, a class action alleges that executives created a false impression about revenue outlook and contract renewals while minimizing risks, and the stock declined approximately 71% after the company announced on May 26, 2026 that it received a termination notice from Avis Budget Group and lowered its full-year 2026 financial outlook. Shareholders who purchased or acquired shares prior to specified dates and still hold them can seek corporate reforms and return of funds at no cost.

Impact on assets 5

Biotech & Genomic Medicine▼ · 2 stocks
GRAIL, LLC
GRAL
▼ NegativeTechnologyrelevance

NHS-Galleri cancer screening trial failed to meet primary endpoint, causing stock to fall over 50% in one day.

GeneDx Holdings Corp.
WGS
▼ NegativeCapitalrelevance

Allegations that executives made false statements about Fabric acquisition improving financials and creating efficiencies, when they knew of significant problems in Fabric's viability.

Climate Adaptation & Water▼ · 1 stocks
Badger Meter Inc
BMI
▼ NegativeDemandrelevance

Allegations that strong financial performance was due to pull-forward of orders masking weakening demand, with disappointing quarterly announcements causing stock declines.

Smart City / Autonomous Infrastructure▼ · 1 stocks
Verra Mobility Corp
VRRM
▼ NegativeDemandrelevance

Received termination notice from Avis Budget Group and lowered full-year 2026 financial outlook, causing stock to decline approximately 71%.

Artificial Intelligence▲ · 1 stocks
© 2026 MarketIVNews